Effective PD-1 monoclonal antibody therapy despite low PD-L1 expression in hidradenocarcinoma: a retrospective review
Published: 4 September 2023| Version 1 | DOI: 10.17632/xm74h8f4rt.1
Contributors:
Jing Lin, Qian Li, Yanping Chen, Li Zhu, Zhiheng Ke, Huishan Zhang, Yufang Huang, Jianping Lu, Huazhen Xiao, Lu Si, Yu ChenDescription
The medical record of 83 patients diagnosed with hidradenocarcinoma from January 2012 to March 2022.The clinical data were collected from 3 centers.
Files
Categories
Clinical Data Collection
Funding
the Natural Science Foundation of Fujian Province
2023J011254
the Science Foundation for The Excellent Youth Scholars of Fujian Provincial Health Commission
2022ZQNZD009
Joint Funds for the Innovation of Science and Technology, Fujian Province
2021Y9227
Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy
2020Y2012